Madrigal Pharmaceuticals, Inc.

MDGL Stock Healthcare Biotechnology
$449.74
-10.07 (-2.19%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-15.8%
3 Months
-16.0%
YTD
-22.8%
1 Year
+3.8%
3 Year annualized
+47.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
43.4%
Largest decline max drawdown, since Oct 2021
-61.4%
Risk-adjusted return Sharpe ratio, 1-year
0.30

Own MDGL?

See how MDGL contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.